Angiotensin II is a strong candidate for the perpetuation of autoimmunity, nephritis and visceral damage in systemic lupus erythematosus (SLE
Introduction
Systemic lupus erythematosus (SLE) is the prototypic autoimmune disease that may affect any organ system. The development of lupus nephritis (LN) is not only common, but is associated with significant morbidity and mortality. 1 Both SLE and end-stage renal disease (ESRD) show clear familial patterns, suggesting a significant genetic component to disease development and/or progression. [2] [3] [4] [5] Angiotensin II (AII), the main effector molecule of the renin angiotensin system (RAS), is a pleiotropic molecule and strong candidate as a mediator of the development and progression of renal disease in SLE. AII is a vasoactive peptide and growth factor that contributes to vascular reactivity, tissue remodeling and fibrosis. 6, 7 AII is also a potent pro-inflammatory modulator with the ability to augment and perpetuate immune responses in renal and non-renal tissues. 8, 9 The synthesis of AII is dependent on angiotensinogen production, which is converted by renin to angiotensin I and then by angiotensin-converting enzyme (ACE) to AII. Our goal for this study was to determine whether three ACE gene polymorphisms are associated with SLE and/or LN. Specifically, we examined three insertion/deletion polymorphisms: Alu I/D (involving a 287 base pair sequence of DNA in intron 16), 23949 (CT) 2/3 (two vs three CT dinucleotides in the 3Ј untranslated region) and 10698 (G) 3/4 (three vs four G nucleotides in intron 13). The Alu I/D and (CT) 2/3 polymorphisms correlate with serum ACE levels. 10 To date, only the ACE I/D polymorphism has been examined in the context of SLE and/or LN, with highly discordant results. [11] [12] [13] [14] [15] [16] [17] [18] In the current study, we examine a large and ethnically diverse sample of SLE patients utilizing a family-based analytic approach, the transmission/ disequilibrium test (TDT).
Results
In the current study, demographic and clinical characteristics of SLE patients differed significantly between the LN and non-LN subgroups ( Table 1) . As a group, the LN patients were more likely to be male and to be non- Caucasian. They also developed SLE at an earlier age and had a longer duration of disease at time of entry to the current study.
S43
We performed a TDT analysis of each of the three ACE polymorphisms using the GENEHUNTER program 19 ( Table 2 ). Statistically significant associations were observed for the ACE I/D polymorphism among nonCaucasian families (61% transmission, P = 0.026) and for the 23949 (CT) 2/3 polymorphism among non-Caucasian LN families (69% transmission, P = 0.014). Since GENE-HUNTER utilizes only fully informative families we also examined the transmission of each of these markers using the FBAT program, 20 which can analyze a larger number of family types. Overall, results obtained in FBAT were similar to those shown for GENEHUNTER. For example, analysis of each of the markers in FBAT revealed stronger evidence of disease association among non-Caucasian families. Results for the entire group of non-Caucasian families (n = 209) were: (G) 3/4 (P = 0.008, recessive model), Alu I/D (P = 0.038, recessive model) and (CT) 2/3 (P = 0.030, recessive model). Results for the (CT) 2/3 marker, non-Caucasian LN families, were also similar to those obtained with the GENEHUNTER program (P = 0.013, dominant model). We have chosen to rely upon the GENEHUNTER results since the use of fully informative families requires fewer assumptions, yielding more robust results. Next, we calculated the extent of linkage disequilibrium between each of the three markers among all families, as well as the Caucasian and non-Caucasian subgroups. We found significant evidence of linkage disequilibrium between each pairwise combination of markers for each of the subgroups. We examined transmission of haplotypes defined by these three markers. Not surprisingly, the most significant results were for the two-marker haplotypes defined by the Alu I/D and (CT) 2/3 markers (Table 3) , since these markers demonstrated the strongest associations in the single marker analyses. Overall, these haplotype associations were more significant than the single marker results. Most striking is the association of the double deletion haplotype [ie, Alu D − (CT) 2 ] with disease among non-Caucasians (81% transmission, P = 0.0046). Interestingly, we also found evidence of a possible protective effect of the I − (CT) 2 haplotype. In contrast to the Alu D − (CT) 2 haplotype that was preferentially transmitted among the non-Caucasian LN group, the nonCaucasian group and all families, the I − (CT) 2 haplotype was preferentially not transmitted, reaching significance in the non-Caucasian non-LN group (9% transmission, P = 0.0067).
Discussion
The results of this study suggest that DNA sequence variation in the ACE gene influences the risk of developing SLE and LN. Our results also suggest ethnic heterogeneity since associations were more striking among the non-Caucasian families.
Previous studies in SLE have been limited to the Alu I/D polymorphism, have involved relatively small numbers of patients from various ethnic populations, and have yielded highly discordant results. For example, some studies have demonstrated association of SLE with the Alu D allele, [11] [12] [13] while others have demonstrated either association with the I allele [14] [15] [16] or no association with either allele. 17, 18 Results have also varied in terms of the specificity of the association, with some studies demonstrating association with SLE in general, [12] [13] [14] [15] and other associations restricted to specific clinical subgroups, such as LN, active LN, or disease activity.
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Genes and Immunity There are a number of potential explanations for these discrepancies. Because previous studies utilized a traditional case control design some of these results may represent spurious results arising due to population admixture. Small sample sizes in some of the previous studies may have led to either false negative or positive results. Differences in disease definition, for example LN or disease activity, may also explain some of these discrepancies. Studies of IgA nephropathy, mixed glomerular disease and diabetic nephropathy suggest that ACE polymorphisms are more consistently associated with the progression of renal disease. [22] [23] [24] Indeed, a previous study of LN among Chinese patients demonstrated association of an Alu I/D genotype with progressive renal disease. 21 Previous studies of ACE polymorphisms in renal and cardiovascular disease demonstrate ethnic heterogeneity with stronger associations in non-Caucasian populations similar to those observed in the current study. 25, 26 Thus, it is likely that some of the inconsistent relationships are the result of ethnic heterogeneity.
There are a number of limitations of the current study. First, although the total number of patients examined was large, the smaller size of individual non-Caucasian subgroups limited the analytic power. Second, there was variation in the amount and type of information available for individual subjects. To compensate for this design feature we obtained all medical records available for each subject since the time of diagnosis. We also collected extensive information from subjects via questionnaire to ensure that we were not missing important data relevant to their SLE diagnoses or the presence of renal involvement. Third, because a minority of patients had developed SLE shortly before entry to the current study, it is possible that some patients who would ultimately develop renal disease were misclassified. Fourth, the three polymorphisms examined did not span the entire gene. To date, at least 13 polymorphisms of the ACE gene have been identified, 27 thus it is possible that examination of additional markers would have revealed different or more striking association with disease. Lastly, because we did not measure serum ACE levels in these patients we were unable to correlate the observed genetic associations with a relevant biologic marker of ACE activity. However, previous studies have documented strong associations between serum levels of ACE and both the Alu D and (CT) 2 deletion alleles. 10 We believe that the associations observed in the current study highlight the potentially important role of the ACE gene and the RAS in the pathophysiology of SLE and LN. In view of the ethnic variation in the results, and the relatively small numbers of patients available for analysis of specific subgroups, additional studies are needed to confirm and extend these results. These studies should include larger numbers of subjects from specific ethnic subgroups, characterization of LN severity and progression, additional polymorphisms in the region, and other genes relevant to the RAS.
Materials and methods
Subjects
We studied a total of 644 SLE patients and 1130 family members, including 878 parents and 252 unaffected siblings. Informed consent was obtained from all patients and the study was approved by the institutional review board at the University of California, San Francisco (UCSF). Study subjects were participants in the UCSF Lupus Genetics Project and were recruited from UCSF Arthritis Clinics, private rheumatology practices in Northern California, and nationwide outreach. All patients fulfilled the American College of Rheumatology (ACR) revised criteria for SLE. 28, 29 Ethnic background was determined based on the ancestries of each subject's four grandparents.
Classification as LN
Patients were classified as LN if they met the ACR renal criteria (28) and/or if they had renal biopsy evidence of lupus nephritis (ie, immune complex deposition). The ACR renal criteria require evidence of persistent proteinuria (ie, Ͼ0.5 gm per 24 hours or +3 if urine dipstick only) or 'active sediment' (ie, cellular casts-red cell, granular, tubular, or mixed). Histopathologic findings were classified according to World Health Organization (WHO) criteria.
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Sample preparation DNA templates for polymerase chain reaction (PCR)-based genotyping were prepared from buccal cell brushings as previously described.
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DNA marker analysis Each ACE polymorphism examined was an insertion/deletion (I/D) that was typed by fragment size 
Statistical methods
Our primary analytic method was the TDT. In brief, the TDT involves comparing the observed rate of transmission of alleles from heterozygous parents to affected offspring to that expected based on Mendelian segregation. Alleles transmitted significantly greater than 50% of the time to affected offspring provide evidence of disease association.
Single marker TDT analyses were performed in GENE-HUNTER 19 and FBAT (family-based association test). 20 We calculated the extent of linkage disequilibrium between the markers using the GOLD program. 32 Transmission of haplotypes was analyzed using GENE-HUNTER. Demographic and clinical characteristics of LN and non-LN patients were compared using the Chisquare test for categorical variables and Student's t-test for continuous variables.
